Gao et al. found that tanshinone IIA (1) reversed sepsis-induced reductions in CD4+ and CD8+ T-cell populations, improved T-cell function in abdominal sepsis, balanced Th1/Th2 cells, and ameliorated immunosuppression in polymicrobial sepsis [65]. This evidence concerns the gene CD8A and Sepsis.